Nefro-Fer (Iron Sucrose)

Iron sucrose is used to correct iron deficiency in conditions where oral iron is insufficient or not tolerated.

• Iron deficiency anemia: restores hemoglobin levels and replenishes iron stores.
• Anemia associated with chronic kidney disease: provides intravenous iron to support erythropoiesis in CKD patients.
• Peri‑operative anemia management: improves iron status before surgery to reduce transfusion need.

• Iron sucrose is a stable iron‑carbohydrate complex that releases elemental iron after intravenous administration. The iron is taken up by reticuloendothelial cells, bound to transferrin, and delivered to the bone marrow for incorporation into hemoglobin, thereby correcting iron deficiency and supporting erythropoiesis. The controlled release limits free iron, reducing oxidative stress, and the complex is cleared within hours, providing a predictable pharmacokinetic profile.

Iron sucrose may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild gastrointestinal upset.
• Headache: transient headache.
• Injection site pain: discomfort at infusion site.
• Muscle cramps: occasional cramping.

Serious or Rare Side Effects

• Hypotension: sudden drop in blood pressure during infusion.
• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Iron overload: excessive iron accumulation with prolonged use.
• Hepatotoxicity: liver enzyme elevations in rare cases.

When using iron sucrose, clinicians should observe several safety measures.

• Assess iron status: confirm iron deficiency before initiating therapy.
• Monitor hemoglobin: check levels regularly to evaluate response.
• Observe during infusion: watch for hypotension or allergic reactions.
• Avoid in patients with known hypersensitivity to iron sucrose or its components.
• Use caution in patients with active infections or liver disease.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iron sucrose can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Concurrent use of other intravenous iron products: may cause iron overload.
• High-dose vitamin C: increases iron absorption and risk of toxicity.
• Certain antibiotics (e.g., quinolones): may chelate iron, reducing efficacy.

Moderate Interactions (Monitor Closely)

• Oral iron supplements: may interfere with laboratory measurement of iron parameters.
• Antihypertensive agents: hypotensive episodes may be potentiated during infusion.
• Erythropoiesis‑stimulating agents: may enhance erythropoietic response, requiring dose adjustment.